MDM2 and liposarcoma: Furthermore, based on The Cancer Genome Atlas (TCGA) analysis5, dedifferentiated liposarcomas exhibit highly recurrent copy-number gains of MDM2, CDK4, and HMGA2. For leiomyosarcomas, deletions or mutations of TP53, RB1, and PTEN were found.